Alyeska Investment Group
TELA icon

Alyeska Investment Group’s TELA Bio TELA Stock Holding History

Alyeska Investment Group’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-235,251
Closed -$3.5M – 834
2021
Q1 		$3.5M Sell
235,251
-112,152
-32% -$1.69M 0.05% 381
2020
Q4 		$5.22M Sell
347,403
-113,794
-25% -$1.85M 0.07% 266
2020
Q3 		$7.63M Sell
461,197
-263,506
-36% -$3.7M 0.12% 217
2020
Q2 		$9.39M Buy
724,703
+527,391
+267% +$6.93M 0.14% 207
2020
Q1 		$1.54M Sell
197,312
-4,159
-2% -$56.2K 0.03% 272
2019
Q4 		$2.61M Buy
+201,471
New +$2.46M 0.03% 277

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Alyeska Investment Group's TELA Position: Q2 2021 in Review

Alyeska Investment Group sold out of TELA Bio (TELA) in Q2 2021, closing a stake of 235,251 shares — an estimated $3.5M sold.

Alyeska Investment Group first reported a position in TELA in Q4 2019 and held it in 6 quarters. The position peaked at $9.39M in Q2 2020. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2021.

  • Alyeska Investment Group reported no remaining TELA Bio position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 235,251 TELA Bio shares in Q2 2021, an estimated $3.5M.
  • Alyeska Investment Group first reported a position in TELA Bio in Q4 2019 and held it in 6 quarters.
  • Alyeska Investment Group's TELA Bio position peaked at $9.39M in Q2 2020.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.